Boom or Bust, VCs Fund Their Best Bets
This article was originally published in Start Up
Executive Summary
Has investment quality suddenly become primary? That's what we're hearing from venture capitalists--when exits are scarce, put most of your money behind your best biotech start-ups. But as the data below makes clear, VCs have always allocated their money disproportionately to their top candidates, regardless of financing conditions.